|
Market Closed -
Bombay S.E.
14:28:06 10/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,840.80 INR | -1.57% |
|
-3.59% | +14.97% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Stock exchange
Bombay S.E.
GLAXO 2,840.80 ₹
-1.57%
5.87M
₹
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLAXO | 2,840.80INR | -1.57% | 5.87M ₹ | ||
NSE India S.E.
| GLAXO | 2,840.90INR | -1.71% | 110M ₹ |
Quotes 5-day view: GlaxoSmithKline Pharmaceuticals Limited
Delayed Quote Bombay S.E.| 04/09/2026 | 07/09/2026 | 08/09/2026 | 09/09/2026 | Today | |
|---|---|---|---|---|---|
| Last | ₹2,958.60 | ₹2,956.95 | ₹2,928.70 | ₹2,886.15 | ₹2,840.80 |
| Volume | 1,734 | 24,980 | 1,897 | 3,416 | 2,065 |
| Change | +0.79% | -0.06% | -0.96% | -1.45% | -1.57% |
| Opening | ₹2,965.55 | ₹2,932.10 | ₹2,941.85 | ₹2,930.00 | ₹2,883.35 |
| High | ₹2,965.55 | ₹3,074.00 | ₹3,000.30 | ₹2,959.55 | ₹2,960.00 |
| Low | ₹2,930.00 | ₹2,932.10 | ₹2,924.60 | ₹2,872.90 | ₹2,836.25 |
Performance
| 1 day | -1.57% | ||
| 1 week | -3.59% | ||
| Current month | -6.95% | ||
| 1 month | +9.55% | ||
| 3 months | +29.45% | ||
| 6 months | +12.65% | ||
| Current year | +14.97% | ||
| 1 year | +0.80% | ||
| 3 years | +94.38% | ||
| 5 years | +86.11% | ||
| 10 years | +89.83% |
Volumes
marketsDaily volume
2,065
Estimated daily volume
2,065
Avg. Volume 20 sessions
25,594
Daily volume ratio
0.08
Avg. Volume 20 sessions INR
72,707,435.2
Avg. Volume 20 sessions USD
761,901.21
Record volume 1
3,666,032
Record volume 2
2,829,462
Record volume 3
2,189,176
Capital turnover ratio
0
Basic data
Market Cap (INR)
491,254,215,774
Market Cap (USD)
5,138,223,197
Net sales (INR)
38,216,700,000
Net sales (USD)
399,723,663
Number of employees
3,103
Sales / Employee (INR)
12,316,049
Sales / Employee (USD)
128,818
Indicators
Moving average 5 days
2,933.15
Moving average 20 days
2,918.82
Moving average 50 days
2,678.84
Moving average 100 days
2,508.66
Price spread / (MMA5)
+3.25%
Price spread / (MMA20)
+2.75%
Price spread / (MMA50)
-5.70%
Price spread / (MMA100)
-11.69%
STIM
RSI 9 days
51.29
RSI 14 days
57.23
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.57% | -3.59% | +0.80% | +94.38% | 5.14B | ||
| +0.39% | -2.64% | +49.60% | +89.56% | 1,002B | ||
| -0.05% | -4.20% | +51.74% | +63.99% | 644B | ||
| +0.73% | -2.99% | +19.28% | +69.37% | 443B | ||
| -0.63% | -3.09% | +29.84% | +36.08% | 343B | ||
| +0.43% | -14.61% | +11.32% | +26.98% | 262B | ||
| +0.93% | -3.19% | -1.31% | +11.96% | 245B | ||
| -2.31% | -13.92% | +37.27% | +46.08% | 212B | ||
| -0.90% | -5.06% | -18.47% | -58.14% | 199B | ||
| -0.55% | -4.29% | +25.58% | +87.87% | 181B | ||
| Average | -0.21% | -4.70% | +20.57% | +46.81% | 353.48B | |
| Weighted average by Cap. | +0.12% | -4.24% | +32.04% | +56.19% |
Historical Quotes: GlaxoSmithKline Pharmaceuticals Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
e1685a.JV6yoOmZ0hgZq_fXe45QN07l-rfUv7h-Ff_yGNexXc0.ES3Wx6Pxs3cu-qK4I9YBTgmiqPmQ-o09e6vCdJb_b6l0ENjJ2qjhbGz7tg
| Date | Price | Volume | Total |
|---|---|---|---|
| 14:28:06 | 2,840.80 | 4 | 2,065 |
| 14:24:02 | 2,840.80 | 5 | 2,061 |
| 14:23:55 | 2,840.80 | 15 | 2,056 |
| 14:23:51 | 2,840.80 | 10 | 2,041 |
| 14:21:30 | 2,840.80 | 1 | 2,031 |
| 13:54:43 | 2,844.40 | 6 | 2,030 |
| 13:54:02 | 2,836.25 | 1 | 2,024 |
| 13:50:28 | 2,836.25 | 2 | 2,023 |
| 13:45:39 | 2,845.25 | 2 | 2,021 |
Price Extremes
| 1 week | 2,836.25 | 3,074 | |
| 1 month | 2,577.9 | 3,121.1 | |
| Current year | 2,088 | 3,121.1 | |
| 1 year | 2,088 | 3,121.1 | |
| 3 years | 1,387.9 | 3,515.95 | |
| 5 years | 1,228 | 3,515.95 | |
| 10 years | 1,020 | 3,515.95 |
Monthly variations
Annual variations
| 2026 | +14.97% | ||
| 2025 | +9.72% | ||
| 2024 | +18.69% | ||
| 2023 | +43.86% | ||
| 2022 | -25.08% | ||
| 2021 | +8.46% | ||
| 2020 | +0.93% | ||
| 2019 | +6.40% | ||
| 2018 | +21.86% | ||
| 2017 | -9.14% | ||
| 2016 | -17.79% | ||
| 2015 | +3.89% | ||
| 2014 | +6.82% | ||
| 2013 | +38.18% | ||
| 2012 | +11.84% | ||
| 2011 | -17.34% | ||
| 2010 | +45.50% | ||
| 2009 | +40.37% | ||
| 2008 | +11.36% | ||
| 2007 | -11.55% | ||
| 2006 | +3.95% | ||
| 2005 | +45.61% | ||
| 2004 | +33.79% | ||
| 2003 | +88.17% | ||
| 2002 | +6.33% | ||
| 2001 | -36.76% | ||
| 2000 | -37.81% | ||
| 1999 | +18.82% | ||
| 1998 | +50.74% | ||
| 1997 | +63.20% | ||
| 1996 | +6.27% |
- Stock Market
- Stocks
- GLAXO Stock
- Quotes GlaxoSmithKline Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions

















